Overview
- 12 inspections across 10 sites are on record.
- 43 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2009-12-03.
At a glance
Inspections
12
Sites
10
Observations
43
Career since
Mar 2008
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Hi-Tech Pharmacal, an AKORN Company | 3 Dec 2009 | On file | |
| Time-Cap Laboratories, Inc. | 29 Jun 2009 | On file | |
| Altaire Pharmaceuticals, Inc. | 28 Apr 2009 | On file | |
| Corwood Labs Inc | 8 Apr 2009 | View 483 → | |
| Intermax Pharmaceuticals, Inc. | 3 Feb 2009 | On file |
Sites inspected
Hi-Tech Pharmacal, an AKORN CompanyAmityville, United States1 insp.
Time-Cap Laboratories, Inc.Farmingdale, United States1 insp.
Altaire Pharmaceuticals, Inc.Aquebogue, United States1 insp.
Corwood Labs IncHauppauge, United States1 insp.
Intermax Pharmaceuticals, Inc.Farmingdale, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
James A Liubicich5 shared
Robert C Horan3 shared
Robert C Steyert3 shared
Paul C Mouris2 shared
Uduak M Inokon1 shared
Dongping Dai1 shared
Dennis E Guilfoyle1 shared
Charisse K Green1 shared
Steven M Weinman1 shared
Xiaokuang Lai1 shared
Full investigator report
Get the verbatim findings behind Gary J Lehr's 43 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site